In the Boardroom
Refine Search
Pharmaceutical
Germany’s Merck KGaA has appointed Udit Batra to head the combined life science business following the pending acquisition of US life science company Sigma-Aldrich. 14 April 2015
Pharmaceutical
Oncology specialist Blend Therapeutics has appointed Drew Fromkin as president and chief executive. 13 April 2015
Pharmaceutical
Takeda Pharmaceuticals USA, the US subsidiary of Japan’s largest drugmaker Takeda, has appointed Ramona Sequeira as president of the US business unit. 13 April 2015
Pharmaceutical
US pharma giant Pfizer has appointed Kathrin Jansen as senior vice president of vaccine research and development. 7 April 2015
Pharmaceutical
Japanese pharma company Santen has appointed Shigeo Taniuchi as head of Santen Europe. 2 April 2015
Pharmaceutical
Christopher Garabedian, chief executive of RNA-targeted therapeutics specialist Sarepta, has resigned from the company. 2 April 2015
Pharmaceutical
EMD Serono, the US biopharma subsidiary of Germany’s Merck KGaA has appointed Frederick Munschauer as vice president of medical affairs, neurology and immunology. 2 April 2015
Pharmaceutical
US pharma company Orexigen Therapeutics has announced that Tom Cannell has joined as chief commercial officer. 30 March 2015
Pharmaceutical
Japanese pharma company Otsuka has announced that its current vice chairman and representative director Ichiro Otsuka is now chairman and representative director. 30 March 2015
Pharmaceutical
Danish company Zealand Pharma is to make organizational and management changes, including splitting research and development divisions. 19 March 2015
Pharmaceutical
USA-based pharma company Inovio Pharmaceuticals has appointed Scott White as vice president of clinical development in infectious diseases. 18 March 2015
Pharmaceutical
Neurotech Pharmaceuticals has appointed Charles Johnson as chief medical officer. 18 March 2015
Pharmaceutical
Privately-held Swiss pharma company Polyphor has appointed Michael Altorfer as its new chief executive. 17 March 2015
Pharmaceutical
HUYA Bioscience International has appointed Alain Rolland as executive vice president and chief scientific officer. 12 March 2015
Pharmaceutical
US oncology and autoimmune biopharma company Lycera has appointed Jeffrey Wilkins to the newly-created chief medical officer position. 9 March 2015
Pharmaceutical
Taiwanese pharma company Twi Pharmaceuticals has appointed Tina Guilder as president and chief executive officer. 5 March 2015
Pharmaceutical
Pharma industry sales force levels in 2014 showed a slowdown in the decline seen in previous years, according to market research company Cegedim Strategic Data (CSD). 5 March 2015
Pharmaceutical
Adaptimmune, a UK biotech company focused on using T-cell therapy to treat cancer and infectious disease, has appointed Rafael Amado as chief medical officer and Adrian Rawcliffe as chief financial officer. 4 March 2015
Pharmaceutical
Canadian cannabinoid therapy specialist InMed Pharmaceuticals has appointed Ado Mohammed as chief medical officer. 4 March 2015
Pharmaceutical
Oncology biopharma company CASI Pharmaceuticals has appointed Rong Chen as chief medical officer. 4 March 2015
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze